Accelerated cutaneous nodulosis during infliximab therapy in a patient with rheumatoid arthritis

Journal of Clinical Rheumatology

Volumn 10, Issue 6, 2004, Pages 336-338

  Mackley, Christine L ^a,b   Ostrov, Barbara E ^a   Ioffreda, Michael D ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Accelerated cutaneous nodulosis; Infliximab; Rheumatoid arthritis

Indexed keywords

INFLIXIMAB;

ADULT; ARTICLE; BIOPSY; CASE REPORT; DISEASE EXACERBATION; FEMALE; GRANULOMA; HAND; HUMAN; NECROSIS; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SKIN NODULE;

EID: 10044238934     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000147054.26777.43     Document Type: Article

References (16)

1. Ziff M. The rheumatoid nodule. Arthritis Rheum. 1990;33:761-767.
2. Cunnane G, Warnock M, Fye KH, et al. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum. 2002;47:445-449.
3. Segal R, Caspi D, Tishler M, et al. Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum. 1988;31:1182-1185.
4. Kerstens PJSM, Boerbooms AMT, Jeurissen MEC, et al. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis: an analysis of ten cases. J Rheumatol. 1992;19:867-871.
5. Abu-Shakra M, Nicol P, Urowitz MB. Accelerated nodulosis, pleural effusion, and pericardial tamponade during methotrexate therapy. J Rheum. 1994;21:934-936.
6. Williams FM, Cohen PR, Arnett FC. Accelerated cutaneous nodulosis during methotrexate therapy in a patient with rheumatoid arthritis. J Am Acad Dermatol. 1998;39:359-362.
7. Filosa G, Salaffi F, Bugatti L. Accelerated nodulosis during methotrexate therapy for refractory rheumatoid arthritis: a case report. Adv Exp Med Biol. 1999;455:521-524.
8. Kekow J, Welte T, Kellner U, et al. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept. Arthritis Rheum. 2002;46:843-844.
9. Ahmed SS, Arnett FC, Smith CA, et al. HLA-DRB1 alleles predict the development of methotrexate-associated accelerated nodulosis syndromes [Abstract]. Arthritis Rheum. 1996;39(suppl):S102.
10. Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med. 1997;337:141-147.
11. Hessian PA, Highton J, Kean A, et al. Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma. Athritis Rheum. 2003;48:334-338.
12. Wikaningrum R, Highton J, Parker A, et al. Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient. Arthritis Rheum. 1998;41:1783-1797.
13. Bautista BB, Boyce EG, Schumacher HR. Effects of second-line drugs on the progression or regression of rheumatoid nodules. J Clin Rheumatol. 1995;1:213-218.
14. Dash S, Seibold JR, Tiku ML. Successful treatment of methotrexate induced nodulosis with d-penicillaraine. J Rheumatol. 1999;26:1396-1398.
15. Jang KA, Choi JH, Moon KC, et al. Methotrexate nodulosis. J Dermatol. 1999;26:460-464.
16. Abraham Z, Rozenbaum M, Rosner I. Colchicine therapy for low-dose-methotrexate-induced accelerated nodulosis in a rheumatoid arthritis patient. J Dermatol. 1999;26:691-694.